MET gene alterations predict poor survival following chemotherapy in patients with advanced cancer

MET gene alterations predict poor survival following chemotherapy in patients with advanced cancer

Background: To aid in oncology drug development, we investigated MET proto-oncogene receptor tyrosine kinase gene aberrations in 2,239 oncology patients who underwent next-generation sequencing (NGS) in clinical practice.Materials and methods: From November 2019 to January 2021, 2,239 patientswith a...

Full description

Bibliographic Details
Main Authors: Jihoon Ko, Jaeyun Jung, Seung Tae Kim, Jung Yong Hong, Sehhoon Park, Joon Oh Park, Young Suk Park, Ho Yeong Lim, Soomin Ahn, Kyoung-Mee Kim, Won Ki Kang, Jeeyun Lee
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-11-01
Series:Pathology and Oncology Research
Subjects:
next-generation sequencing
oncogene
overall survival analysis
MET
MET alterations
chemotherapy
Online Access:https://www.por-journal.com/articles/10.3389/pore.2022.1610697/full

Internet

https://www.por-journal.com/articles/10.3389/pore.2022.1610697/full

Similar Items